Glioma clinical trials in Nebraska
6 studies for Glioma are looking for participants at sites in Nebraska.
Cities in Nebraska
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Oct 1, 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Nebraska Medical Center, Omaha
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 14, 2026 · NCT05698524A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1/2
Ages 19 and older · All sexes · Updated Jun 8, 2026 · NCT06011109A Study Utilizing Escitalopram in Glioma Patients
- University of Nebraska Medical Center, Omaha
RecruitingPhase 2
Ages 19 and older · All sexes · Updated Apr 17, 2026 · NCT03728673From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.